Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Hungarian (BUX) Healthcare Sector Analysis

UpdatedJul 21, 2026
DataAggregated Company Financials
Companies3
  • 7D0.2%
  • 3M-9.5%
  • 1Y15.8%
  • YTD20.1%

The Healthcare industry has stayed flat over the last week. As for the the longer term, the industry is up 17% over the past 12 months. Looking forward, earnings are expected to remain mostly flat in the next few years.

Sector Valuation and Performance

Has the Hungarian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 21 Jul 2026Ft2.2tFt931.5bFt231.4b9.5x9.6x2.4x
Thu, 18 Jun 2026Ft2.2tFt931.5bFt231.4b9.4x9.5x2.4x
Sat, 16 May 2026Ft2.3tFt931.5bFt231.3b10x10.1x2.5x
Mon, 13 Apr 2026Ft2.4tFt935.4bFt234.2b10x10.1x2.5x
Wed, 11 Mar 2026Ft2.2tFt935.4bFt234.1b9.2x9.3x2.3x
Fri, 06 Feb 2026Ft2.1tFt907.7bFt229.0b9.1x9.2x2.3x
Sun, 04 Jan 2026Ft1.8tFt907.7bFt229.0b8.2x8x2x
Tue, 02 Dec 2025Ft1.8tFt907.7bFt229.0b9.2x7.8x2x
Thu, 30 Oct 2025Ft1.9tFt909.8bFt222.7b9.8x8.7x2.1x
Sat, 27 Sep 2025Ft1.8tFt909.5bFt222.9b8.1x8.2x2x
Mon, 25 Aug 2025Ft2.0tFt909.5bFt222.9b8.8x8.9x2.2x
Wed, 23 Jul 2025Ft1.9tFt884.3bFt241.0b7.8x7.9x2.2x
Fri, 20 Jun 2025Ft1.9tFt884.3bFt241.0b7.8x7.9x2.2x
Sun, 18 May 2025Ft2.0tFt884.3bFt241.0b8.1x8.2x2.2x
Tue, 15 Apr 2025Ft1.9tFt857.5bFt239.7b6.9x8x2.2x
Thu, 13 Mar 2025Ft1.9tFt857.5bFt239.7b7.3x8x2.2x
Sat, 08 Feb 2025Ft1.9tFt839.6bFt212.1b7.9x9.2x2.3x
Mon, 06 Jan 2025Ft2.0tFt839.6bFt212.1b8.1x9.2x2.3x
Wed, 04 Dec 2024Ft1.9tFt839.6bFt212.1b7.4x9.2x2.3x
Fri, 01 Nov 2024Ft2.0tFt811.4bFt229.6b7.4x8.8x2.5x
Sun, 29 Sep 2024Ft2.0tFt811.4bFt229.3b12.6x8.9x2.5x
Tue, 27 Aug 2024Ft2.0tFt811.4bFt229.3b13.1x8.7x2.4x
Thu, 25 Jul 2024Ft1.9tFt798.9bFt188.0b11x9.9x2.3x
Sat, 22 Jun 2024Ft1.7tFt798.9bFt187.9b19.3x9.2x2.2x
Mon, 20 May 2024Ft1.7tFt798.9bFt187.9b19.3x9.2x2.2x
Wed, 17 Apr 2024Ft1.7tFt805.2bFt158.9b20.6x10.9x2.2x
Fri, 15 Mar 2024Ft1.7tFt805.2bFt158.9b21.2x10.9x2.2x
Sun, 11 Feb 2024Ft1.9tFt825.9bFt82.1b27.1x22.7x2.3x
Tue, 09 Jan 2024Ft1.7tFt825.9bFt82.1b25.3x20.8x2.1x
Thu, 07 Dec 2023Ft1.7tFt825.9bFt82.1b26.2x20.6x2x
Sat, 04 Nov 2023Ft1.7tFt855.2bFt110.0b21.1x15.2x2x
Mon, 02 Oct 2023Ft1.7tFt855.2bFt110.1b14.2x15.3x2x
Wed, 30 Aug 2023Ft1.7tFt855.2bFt110.1b14.4x15.8x2x
Fri, 28 Jul 2023Ft1.7tFt844.4bFt157.9b11.7x10.6x2x
Price to Earnings Ratio

10.6x


Total Market Cap: Ft1.7tTotal Earnings: Ft157.9bTotal Revenue: Ft844.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Hungarian Healthcare Sector Price to Earnings3Y Average 10.9x202420252026
Current Industry PE
    There are only 3 companies in the Hungarian Healthcare industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 14% per year over the last three years.
  • Revenues for these companies have grown 3.3% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Hungarian Healthcare sector?

HU Market-0.076%
Healthcare0.25%
Pharma0.25%
Industry PE
  • Investors are most optimistic about the Pharma industry even though it's trading below its 3-year average PE ratio of 10.9x.
    • Analysts are expecting annual earnings growth of 0.7%, which is lower than the prior year's growth of 15.1% per year.
  • Investors are most pessimistic about the Pharma industry, which is trading below its 3-year average of 10.9x.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 0.7% over the next 5 years.
  • In contrast, the Pharma industry is expected to see its earnings growth to stay flat over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available

Latest News

RICHTER
Ft11,780.00
Gedeon Richter
7D
-2.1%
1Y
14.8%
Narrative Update • Jun 26

RICHTER: Future Diabetes Franchise And Dividend Policy Will Shape Balanced Outlook

Analysts have adjusted their fair value estimate for Gedeon Richter from HUF 11,949 to HUF 12,931, reflecting updated assumptions around the discount rate, revenue growth, profit margins, and a higher future P/E expectation. What's in the News Gedeon Richter and Hetero Labs signed a global collaboration agreement for the joint development, registration, and commercialization of Semaglutide Injection, a generic version of Ozempic.
NUTEX
Ft12.70
NUTEX Investments
7D
-4.9%
1Y
-24.4%